← European Medicine Shortage Tracker · all medicines

Terazosin shortage — availability across Europe

Terazosin currently has availability issues reported in 4 European registers: Austria, Germany, Ireland, Italy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Shortage  ATC C02CA · also listed as: TERAZOSIN HYDROCHLORID · Terazosinhydrochlorid-Dihydrat · Terazosin · TERAZOSINA · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 4 of the 10 tracked registers list current availability issues for Terazosin, covering 10 affected product presentations. The longest-running open report was filed in Austria on 2018-05-16 and has now been open for about 99 months. Where agencies state a cause, unexpectedly high demand lead with 3 of the 6 stated-cause reports, followed by manufacturing problems with 2. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-08-31. The issue spread across registers over time rather than at once: Austria reported first (2018-05-16), with Italy following roughly 78 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Ireland, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Terazosin is coded C02CA — a medicine acting on the cardiovascular system — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇦🇹 AustriaLimited availability
Vicard 1 mg - Tabletten
2018-05-16register ↗
🇩🇪 GermanyShortage
Heitrin 1mg
+ 5 more products
Heitrin 2mg
Heitrin 5mg
Tera TAD 10mg
Tera TAD 2mg
Tera TAD 5mg
2024-07-012026-12-31Erhöhte Nachfrage
Alternatives: Terazosin STADA 2 mg Tabletten - Einreichungsnummer: 2156948
register ↗
🇮🇪 IrelandShortage
Hytrin 2mg Tablets
2023-07-05Manufacturing delay (Ireland & UK)
Alternatives: Alternative(s) available — see the national register.
register ↗
🇮🇹 ItalyShortage
TERAZOSINA ZENTIVA
+ 1 more products
TERAZOSINA ZENTIVA
2024-11-30Problemi produttivi
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗

New register reports per month

2024-07: 22024-08: 02024-09: 02024-10: 02024-11: 42024-12: 02025-01: 12025-02: 02025-03: 02025-04: 12024-072025-04

Full report history (10 register entries)

Every individual register entry for Terazosin in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇩🇪 DEHeitrin 2mgShortage2025-04-102026-12-31Erhöhte Nachfrage
🇮🇹 ITTERAZOSINA ZENTIVAShortage2025-01-31Motivi commerciali
🇮🇹 ITTERAZOSINA ZENTIVAShortage2024-11-30Problemi produttivi
🇩🇪 DETera TAD 10mgShortage2024-11-082026-08-31Sonstige
🇩🇪 DETera TAD 2mgShortage2024-11-082026-08-31Sonstige
🇩🇪 DETera TAD 5mgShortage2024-11-082026-08-31Sonstige
🇩🇪 DEHeitrin 1mgShortage2024-07-012026-12-31Erhöhte Nachfrage
🇩🇪 DEHeitrin 5mgShortage2024-07-012026-12-31Erhöhte Nachfrage
🇮🇪 IEHytrin 2mg TabletsShortage2023-07-05Manufacturing delay (Ireland & UK)
🇦🇹 ATVicard 1 mg - TablettenLimited availability2018-05-16

Frequently asked

Is Terazosin currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Austria, Germany, Ireland, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Terazosin shortage expected to end?

Agency prognoses on file range from 2026-08-31 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Terazosin?

9 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Terazosin availability data come from?

Directly from the official medicines-agency registers that list Terazosin: BASG (Austria), BfArM (Germany), HPRA (Ireland), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Terazosin — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/terazosin/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Terazosin availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/terazosin/">Terazosin shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Terazosin: availability status across 4 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.